Exploring the ticagrelor-statin interplay in the PLATO trial
JJ DiNicolantonio, VL Serebruany - Cardiology, 2013 - karger.com
Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Exploring the Ticagrelor-Statin Interplay in the PLATO Trial
JJ DiNicolantonio, VL Serebruany - Cardiology, 2013 - karger.com
Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Exploring the Ticagrelor-Statin Interplay in the PLATO Trial
JJ Dinicolantonio, VL Serebruany - Cardiology, 2013 - search.proquest.com
Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
[PDF][PDF] Exploring the Ticagrelor-Statin Interplay in the PLATO Trial
JJ DiNicolantonio, VL Serebruany - 2013 - researchgate.net
Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Exploring the ticagrelor-statin interplay in the PLATO trial
JJ Dinicolantonio, VL Serebruany - Cardiology, 2013 - pure.johnshopkins.edu
Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Exploring the ticagrelor-statin interplay in the PLATO trial.
JJ Dinicolantonio, VL Serebruany - Cardiology, 2013 - europepmc.org
Results The background statin use in hospital or at discharge was similar between ticagrelor
(89.7%) and clopidogrel (89.2%) PLATO arms, respectively. In patients on statins, ticagrelor …
(89.7%) and clopidogrel (89.2%) PLATO arms, respectively. In patients on statins, ticagrelor …
Exploring the Ticagrelor-Statin Interplay in the PLATO Trial.
JJ DiNicolantonio, VL Serebruany - Cardiology, 2013 - search.ebscohost.com
Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Exploring the ticagrelor-statin interplay in the PLATO trial
JJ Dinicolantonio, VL Serebruany - Cardiology, 2013 - pubmed.ncbi.nlm.nih.gov
Context Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …
Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction …